GlassScriptPhysician profile
Melissa J Cometti
NPI 1639677289
$1,552.15
in general payments reported to CMS, 2019-2025
19 companies · $457 in 2025
The $457 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $54.86 · 2022: $78.02 · 2023: $352 · 2024: $610 · 2025: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,419.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $243.62 | 2024-2025 | Puraply Wound Matrix, Apligraf, Affinity |
| Solventum Corporation | $208.69 | 2024 | Activ.A.C., Promogran Prisma, V.A.C.Ulta |
| Convatec INC. | $170.43 | 2022-2025 | |
| Abbott Laboratories | $133.10 | 2024 | Proclaim |
| Smith+Nephew, INC. | $125.11 | 2021-2025 | Collagenase Santyl |
| Astrazeneca Pharmaceuticals LP | $110.72 | 2023 | Lokelma |
| Hydrofera LLC | $102.58 | 2023-2024 | Hydrofera Blue, Cutimed Sorbact |
| Silk Road Medical, INC. | $93.71 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Aurinia Pharma U.S., INC. | $68.90 | 2024 | Lupkynis |
| Abiomed | $64.05 | 2024 | Impella |
| Kci USA, INC. | $51.50 | 2023 | V.A.C. Veraflo, Promogran Prisma, V.A.C. Dermatac |
| Hollister Incorporated | $41.39 | 2022 | |
| Hartmann USA, INC. | $41.01 | 2025 | Zetuvit Plus 10x10 P10, Colactive Plus 2x2 |
| Tactile Systems Technology INC | $19.53 | 2025 | Flexitouch Plus, Nimbl |
| Kerecis Limited | $18.85 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $17.56 | 2024 | Tcc-Ez |
| Stimlabs LLC | $14.80 | 2025 | Corplex P |
| Mimedx Group, INC. | $14.42 | 2024 | |
| Biowound Solutions, INC. | $12.18 | 2025 | Bio-Connekt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Cometti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.